SCHEMBL26857155

SCHEMBL26857155

Nc1nc2ccc(-c3csc(C(=O)NCc4cccs4)c3)cn2n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 1/20 0.43
▸ RAB9A P51151 7/20 0.41
▸ NPC1 O15118 5/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TSHR P16473 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ HPGD P15428 5/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ MMP12 P39900 1/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26856882 0.86 MMP12 (0.53) TTKTSHRLMNAMMP12PIK3CD
SCHEMBL26857159 0.85 ALDH1A1 (0.45) RAB9ANPC1KDM4ETSHRHPGD
SCHEMBL26857153 0.85 MMP12 (0.42) TTKMMP12PIK3CDPIK3CGMAPK1
SCHEMBL26857108 0.84 PIK3CG (0.39) MMP12PIK3CDPIK3CGMAPK1
SCHEMBL26857148 0.84 MARK3 (0.46) TTKMMP12PIK3CDPIK3CG
SCHEMBL26857043 0.84 ADORA2A (0.40) TTKMMP12PIK3CDPIK3CGMAPK1
SCHEMBL26857037 0.83 MAPK1 (0.47) TSHRGAAPKMHPGDSMN1; SMN2
SCHEMBL26857050 0.83 MMP12 (0.47) KDM4ELMNAMMP12PIK3CDPIK3CG
SCHEMBL26857023 0.83 PIK3CG (0.41) TTKRAB9ANPC1SMN1; SMN2MMP12
SCHEMBL26857044 0.83 MMP12 (0.42) TTKMMP12PIK3CDPIK3CGMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 TTK 2266/4885RAB9A 2286/4885NPC1 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback